| # | Title | Journal | Year | Citations |
|---|
| 1 | Diabetes and its drivers: the largest epidemic in human history? | Clinical Diabetes and Endocrinology | 2017 | 227 |
| 2 | Global epidemiology of prediabetes - present and future perspectives | Clinical Diabetes and Endocrinology | 2019 | 202 |
| 3 | The challenges of diagnosing osteoporosis and the limitations of currently available tools | Clinical Diabetes and Endocrinology | 2018 | 135 |
| 4 | Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports | Clinical Diabetes and Endocrinology | 2019 | 125 |
| 5 | Peer support of complex health behaviors in prevention and disease management with special reference to diabetes: systematic reviews | Clinical Diabetes and Endocrinology | 2017 | 124 |
| 6 | Hypophysitis: Evaluation and Management | Clinical Diabetes and Endocrinology | 2016 | 92 |
| 7 | Management of diabetes mellitus in patients with chronic kidney disease | Clinical Diabetes and Endocrinology | 2015 | 88 |
| 8 | Thyroid nodule update on diagnosis and management | Clinical Diabetes and Endocrinology | 2016 | 81 |
| 9 | The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY) | Clinical Diabetes and Endocrinology | 2020 | 78 |
| 10 | The relationship between diabetes mellitus and 30-day readmission rates | Clinical Diabetes and Endocrinology | 2017 | 76 |
| 11 | Diabetes mellitus and bone health: epidemiology, etiology and implications for fracture risk stratification | Clinical Diabetes and Endocrinology | 2018 | 69 |
| 12 | Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand? | Clinical Diabetes and Endocrinology | 2020 | 60 |
| 13 | Managing diabetes in the digital age | Clinical Diabetes and Endocrinology | 2015 | 56 |
| 14 | Understanding the manifestation of diabetes in sub Saharan Africa to inform therapeutic approaches and preventive strategies: a narrative review | Clinical Diabetes and Endocrinology | 2019 | 54 |
| 15 | Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) | Clinical Diabetes and Endocrinology | 2018 | 51 |
| 16 | Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus | Clinical Diabetes and Endocrinology | 2016 | 45 |
| 17 | Graves’ hyperthyroidism in pregnancy: a clinical review | Clinical Diabetes and Endocrinology | 2018 | 45 |
| 18 | Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians | Clinical Diabetes and Endocrinology | 2021 | 45 |
| 19 | Driving and diabetes: problems, licensing restrictions and recommendations for safe driving | Clinical Diabetes and Endocrinology | 2015 | 44 |
| 20 | Screening and diagnosis of gestational diabetes mellitus – relevance to low and middle income countries | Clinical Diabetes and Endocrinology | 2016 | 43 |
| 21 | Diabetic retinopathy: research to clinical practice | Clinical Diabetes and Endocrinology | 2017 | 41 |
| 22 | Level of adherence to dietary recommendations and barriers among type 2 diabetic patients: a cross-sectional study in an Ethiopian hospital | Clinical Diabetes and Endocrinology | 2018 | 40 |
| 23 | The cost-effectiveness of diabetes prevention: results from the Diabetes Prevention Program and the Diabetes Prevention Program Outcomes Study | Clinical Diabetes and Endocrinology | 2015 | 39 |
| 24 | A clinician’s guide to understanding resistance to thyroid hormone due to receptor mutations in the TRα and TRβ isoforms | Clinical Diabetes and Endocrinology | 2017 | 36 |
| 25 | Update on medical treatment for Cushing’s disease | Clinical Diabetes and Endocrinology | 2016 | 33 |
| 26 | The relationship between depression and risk of metabolic syndrome: a meta‐analysis of observational studies | Clinical Diabetes and Endocrinology | 2021 | 33 |
| 27 | Challenges in diagnosis and management of diabetes in the young | Clinical Diabetes and Endocrinology | 2016 | 31 |
| 28 | Thyroid dysfunction in metabolic syndrome patients and its relationship with components of metabolic syndrome | Clinical Diabetes and Endocrinology | 2016 | 31 |
| 29 | Interpretation of common endocrine laboratory tests: technical pitfalls, their mechanisms and practical considerations | Clinical Diabetes and Endocrinology | 2019 | 31 |
| 30 | The association of dyslipidemia and obesity with glycated hemoglobin | Clinical Diabetes and Endocrinology | 2015 | 30 |
| 31 | Prevalence of Gestational Diabetes Mellitus in urban and rural Tamil Nadu using IADPSG and WHO 1999 criteria (WINGS 6) | Clinical Diabetes and Endocrinology | 2016 | 29 |
| 32 | Pheochromocytoma and Paraganglioma in Neurofibromatosis type 1: frequent surgeries and cardiovascular crises indicate the need for screening | Clinical Diabetes and Endocrinology | 2018 | 29 |
| 33 | Transition from pediatric to adult care in emerging adults with type 1 diabetes: a blueprint for effective receivership | Clinical Diabetes and Endocrinology | 2019 | 29 |
| 34 | The association of depression and diabetes across methods, measures, and study contexts | Clinical Diabetes and Endocrinology | 2018 | 28 |
| 35 | The Nurse Education and Transition (NEAT) model: educating the hospitalized patient with diabetes | Clinical Diabetes and Endocrinology | 2016 | 27 |
| 36 | Lipoprotein (a), an independent cardiovascular risk marker | Clinical Diabetes and Endocrinology | 2016 | 26 |
| 37 | Renin Angiotensin system-modifying therapies are associated with improved pulmonary health | Clinical Diabetes and Endocrinology | 2017 | 26 |
| 38 | Growth hormone: isoforms, clinical aspects and assays interference | Clinical Diabetes and Endocrinology | 2018 | 26 |
| 39 | Management of macroprolactinomas | Clinical Diabetes and Endocrinology | 2015 | 23 |
| 40 | Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface | Clinical Diabetes and Endocrinology | 2016 | 23 |
| 41 | Charcot stage 0: A review and consideratons for making the correct diagnosis early | Clinical Diabetes and Endocrinology | 2015 | 22 |
| 42 | The association between Helicobacter pylori and obesity: a systematic review and meta-analysis of case–control studies | Clinical Diabetes and Endocrinology | 2021 | 20 |
| 43 | Physician knowledge of a rare foot condition – influence of diabetic patient population on self-described knowledge and treatment | Clinical Diabetes and Endocrinology | 2017 | 18 |
| 44 | Perspectives on the impact of painful diabetic peripheral neuropathy in a multicultural population | Clinical Diabetes and Endocrinology | 2017 | 18 |
| 45 | Why do endocrine profiles in elite athletes differ between sports? | Clinical Diabetes and Endocrinology | 2018 | 18 |
| 46 | Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations | Clinical Diabetes and Endocrinology | 2020 | 18 |
| 47 | Isolated ACTH deficiency during single-agent pembrolizumab for squamous cell lung carcinoma: a case report | Clinical Diabetes and Endocrinology | 2020 | 18 |
| 48 | Efficacy of radioactive iodine treatment of graves’ hyperthyroidism using a single calculated 131I dose | Clinical Diabetes and Endocrinology | 2018 | 17 |
| 49 | Natural history of ROHHAD syndrome: development of severe insulin resistance and fatty liver disease over time | Clinical Diabetes and Endocrinology | 2019 | 17 |
| 50 | Maturity-onset diabetes of the young type 5 a MULTISYSTEMIC disease: a CASE report of a novel mutation in the HNF1B gene and literature review | Clinical Diabetes and Endocrinology | 2020 | 17 |
